Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Singulair Added to Flonase for Perennial Allergic Rhinitis
NCT00119015Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Jul 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in perennial allergic rhinitis (PAR), sponsored by University of Chicago. Started Jul 2005; status: terminated.
02
Drugs
montelukast
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00119015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119015.